Abandonment of antiretroviral therapy: A potential barrier to scale-up inn sub-Saharan Africa

被引：0
|
作者：
Reid, Stewart E. [1 ,2 ]
Mulenga, Lloyd B. [2 ]
Folk, William R. [3 ]
Tambatamba, Bushimbwa C. [4 ]
Chi, Benjamin H. [1 ,2 ]
机构：
[1] Univ Alabama, Birmingham, AL 35294 USA
[2] Ctr Infect Dis Res Zambia, Lusaka, Zambia
[3] Univ Missouri, Sch Med, Columbia, MO USA
[4] Lusaka Dist Hlth Management Team, Minist Hlth, Lusaka, Zambia
来源：
SAMJ SOUTH AFRICAN MEDICAL JOURNAL | 2008年 / 98卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：448 / +
页数：2
相关论文
共 50 条
  • [1] Formative evaluation of antiretroviral therapy scale-up efficiency in sub-Saharan Africa
    Wagner, Glenn
    Ryan, Gery
    Taylor, Stephanie
    AIDS PATIENT CARE AND STDS, 2007, 21 (11) : 871 - 887
  • [2] Scale-up of antiretroviral therapy in sub-Saharan Africa - priorities for public health research
    Jaffar, Shabbar
    Mbidde, Edward
    Robb, Alistair
    Coutinho, Alex
    Muwanga, Moses
    Obermeyer, Carla Makhlouf
    Weller, Ian
    Hart, Graham
    Smith, Peter G.
    Haines, Andy
    Grosskurth, Heiner
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2007, 12 (09) : 1009 - 1010
  • [3] Antiretroviral therapy in sub-Saharan Africa
    Müller, O
    Corrah, T
    Katabira, E
    Plummer, F
    Mabey, D
    LANCET, 1998, 351 (9095): : 68 - 68
  • [4] Characterising the scale-up and performance of antiretroviral therapy programmes in sub-Saharan Africa: an observational study using growth curves
    Bigelow, Benjamin
    Verguet, Stephane
    BMJ OPEN, 2020, 10 (09):
  • [5] The potential impact of antiretroviral therapy on fertility in sub-Saharan Africa
    Kaida A.
    Andia I.
    Maier M.
    Strathdee S.A.
    Bangsberg D.R.
    Spiegel J.
    Bastos F.I.
    Gray G.
    Hogg R.
    Current HIV/AIDS Reports, 2006, 3 (4) : 187 - 194
  • [6] Delivery of antiretroviral therapy in sub-Saharan Africa
    Weller, Ian
    CLINICAL INFECTIOUS DISEASES, 2006, 43 (06) : 777 - 778
  • [7] Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes
    May, Margaret
    Boulle, Andrew
    Phiri, Sam
    Messou, Eugene
    Myer, Landon
    Wood, Robin
    Keiser, Olivia
    Sterne, Jonathan A. C.
    Dabis, Francois
    Egger, Matthias
    LANCET, 2010, 376 (9739): : 449 - 457
  • [8] Challenges of scale-up to dolutegravir-based regimens in sub-Saharan Africa
    Salou, Mounerou
    Butel, Christelle
    Comlan, Adjo S.
    Konou, Abla A.
    Tegueni, Kokou
    Ehlan, Amivi
    Lack, Fiali
    Dossim, Sika
    Ayouba, Ahidjo
    Delaporte, Eric
    Dagnra, Anoumou Y.
    Peeters, Martine
    AIDS, 2020, 34 (05) : 783 - 787
  • [9] Determinants of antiretroviral therapy coverage in Sub-Saharan Africa
    Furuoka, Fumitaka
    Hoque, Mohammad Zahirul
    PEERJ, 2015, 3
  • [10] Antiretroviral therapy in sub-Saharan Africa: myth or reality?
    Kebba, A
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (05) : 747 - 749
12345